secwatch / observer
8-K filed February 20, 2024, 6:59 PM ET ticker ISPR CIK 0001948455
earnings confidence high sentiment negative materiality 0.75

Ispire Q2 revenue $41.7M (+30.7%), net loss $4.0M vs -$0.1M YoY; cannabis vaping sales +149%

Ispire Technology Inc.

2024-Q2 EPS reported -$0.10 revenue$84,550,208

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ispire Technology Inc. reported the fiscal second quarter ended December 31, 2023 results: revenue $41.7 million, net income Net loss of $4.0 million, EPS $(0.07) per share.

Period
the fiscal second quarter ended December 31, 2023
Revenue
$41.7 million
Net income
Net loss of $4.0 million
EPS
$(0.07) per share
Result
reported results
Exact text from the filing
Fiscal Second Quarter 2024 Financial Results ● Revenue increased 30.7% to $41.7 million as compared to $31.9 million in the same period of 2023.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ispire Technology Inc. reported the six-month period ended December 31, 2023 results: revenue $84.5 million, net income net loss was approximately $5.4 million, EPS $(0.10) per share.

Period
the six-month period ended December 31, 2023
Revenue
$84.5 million
Net income
net loss was approximately $5.4 million
EPS
$(0.10) per share
Result
reported results
Exact text from the filing
For the six-month period ended December 31, 2023, Ispire reported revenue of $84.5 million, compared to $58.8 million during the same period last year, an increase of 43.7%.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ispire Technology Inc. reported fiscal year 2024, which ends on June 30, 2024 results: revenue Revenue for cannabis vaping products for fiscal year 2024 is projected to be in the range of $80 million to $90 million. Guidance initiated.

Period
fiscal year 2024, which ends on June 30, 2024
Revenue
Revenue for cannabis vaping products for fiscal year 2024 is projected to be in the range of $80 million to $90 million
Guidance
initiated
Result
guidance update
Exact text from the filing
Fiscal Year 2024 Outlook Ispire is providing the following outlook for the cannabis and tobacco vaping products for fiscal year 2024, which ends on June 30, 2024. Revenue for cannabis vaping products for fiscal year 2024 is projected to be in the range of $80 million to $90 million, representing growth of 100% to 125% from fiscal year 2023.
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Ispire Technology Inc. filing history →

Source: SEC EDGAR
accession 0001213900-24-015398
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.